Last reviewed · How we verify
two over-the-counter analgesics
two over-the-counter analgesics is a Nonsteroidal anti-inflammatory drugs (NSAIDs) Small molecule drug developed by Rutgers, The State University of New Jersey. It is currently in Phase 3 development for Relief of minor aches and pains, such as headaches and muscle aches, Reduction of inflammation and fever.
Two over-the-counter analgesics work by reducing pain and inflammation through various mechanisms.
Two over-the-counter analgesics work by reducing pain and inflammation through various mechanisms. Used for Relief of minor aches and pains, such as headaches and muscle aches, Reduction of inflammation and fever.
At a glance
| Generic name | two over-the-counter analgesics |
|---|---|
| Sponsor | Rutgers, The State University of New Jersey |
| Drug class | Nonsteroidal anti-inflammatory drugs (NSAIDs) |
| Modality | Small molecule |
| Therapeutic area | Pain management |
| Phase | Phase 3 |
Mechanism of action
One analgesic may block pain signals to the brain, while the other may reduce inflammation by inhibiting enzymes involved in the production of prostaglandins.
Approved indications
- Relief of minor aches and pains, such as headaches and muscle aches
- Reduction of inflammation and fever
Common side effects
- Gastrointestinal upset
- Stomach ulcers
- Allergic reactions
Key clinical trials
- Comparing Over the Counter Pain Medicines for Discomfort in Crohn's Disease (AVID-CD) (NA)
- Opioid Analgesic Reduction Study (PHASE3)
- Individual Differences in Placebo Analgesic Effects (NA)
- Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug (PHASE2)
- Are Supervised Exercises and TENS Necessary Along With Prescribed Home Exercises for Chronic Low Back Pain? (NA)
- Gabapentin for Pain Control After Osmotic Dilator Insertion and Prior to D&E Procedure: a Randomized Controlled Trial (PHASE4)
- Pilot Study to Define the Immune Response Following Cryoablation of Invasive Breast Cancer (NA)
- Investigation of Efficacy of Improved Acetaminophen Labeling
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- two over-the-counter analgesics CI brief — competitive landscape report
- two over-the-counter analgesics updates RSS · CI watch RSS
- Rutgers, The State University of New Jersey portfolio CI
Frequently asked questions about two over-the-counter analgesics
What is two over-the-counter analgesics?
How does two over-the-counter analgesics work?
What is two over-the-counter analgesics used for?
Who makes two over-the-counter analgesics?
What drug class is two over-the-counter analgesics in?
What development phase is two over-the-counter analgesics in?
What are the side effects of two over-the-counter analgesics?
Related
- Drug class: All Nonsteroidal anti-inflammatory drugs (NSAIDs) drugs
- Manufacturer: Rutgers, The State University of New Jersey — full pipeline
- Therapeutic area: All drugs in Pain management
- Indication: Drugs for Relief of minor aches and pains, such as headaches and muscle aches
- Indication: Drugs for Reduction of inflammation and fever
- Compare: two over-the-counter analgesics vs similar drugs
- Pricing: two over-the-counter analgesics cost, discount & access